Devanthinic Pharma SRL
8.4 FTEThe score of Devanthinic Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +48 % Total assets +17 % Headcount (avg FTE) +71 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Devanthinic Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 26 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Devanthinic Pharma's financial analysis
- Solvency46.0%sector median: 46.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Devanthinic Pharma
Devanthinic Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0506.893.294
- VAT number
- BE0506893294
- Peppol
- Registered · 0208:0506893294 · as of 28 Oct 2026
- Legal form
- SRL
- Incorporated
- 16 Dec 2014
- Registered office
- 7180 Seneffe
- Size
- Micro · 8.4 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Devanthinic Pharma (SRL) has been based in Seneffe since 2014, active in: activities of holding companies. For 2025, it reports a net profit of 888,590 € and equity of €7.73m; its revenue is not published. With 8.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 46.0%, below the median of its sector (46.9%).
Companies similar to Devanthinic Pharma
Companies in the same business, of comparable size and area, outside its group.
- Antwerp Pharmacies Retail sale of pharmaceutical products Sint-Truiden · balance sheet €16.9m
- Silesam Activities of holding companies Roeselare · balance sheet €42.5m
- Biognost Filia Activities of holding companies Kortrijk · balance sheet €17.3m
- Wisli Invest Activities of holding companies Beernem · balance sheet €28.4m
- JM Capital Activities of holding companies Ranst · balance sheet €23.2m
- Pharmasova Activities of holding companies Anderlecht · balance sheet €38.9m
- Palex Healthcare Group Belgium Activities of holding companies Mechelen · balance sheet €26.8m
- Curarix Business and other management consultancy activities Kortrijk · balance sheet €19.3m
Frequently asked questions about Devanthinic Pharma
What is the revenue of Devanthinic Pharma?
Devanthinic Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Devanthinic Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0506893294 for Devanthinic Pharma, if the company is VAT-registered. Its company number (CBE) is 0506.893.294.
Where is the registered office of Devanthinic Pharma?
According to the CBE register, the registered office of Devanthinic Pharma is in 7180 Seneffe.
What is the equity of Devanthinic Pharma?
At the close of the 2025 financial year, the equity of Devanthinic Pharma amounts to 7,733,953 €, a solvency of 46.0% of total assets.
How many people work at Devanthinic Pharma?
8.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Devanthinic Pharma?
The register lists 1 active mandates at Devanthinic Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Devanthinic Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →